ABC1183 was screened by ThermoFisher Scientific SelectScreen services (Waltham, MA) at a single 10-μM dose against a panel of 414 human kinases using ATP at Km [app]. All kinases were screened in duplicate and data were confirmed to meet stringent quality control standards for reproducibility. Kinases inhibited by greater than 60% were further confirmed through dose response IC50 assays, carried out by ThermoFisher Scientific.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.